7. Zhang H, Deng YM, Chen ZC, et al. Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients[J]. Eur Rev Med Pharmacol Sci, 2020, 24(14):7664-...
We recognize the challenges facing nursing homes and the providers who care for their residents. We work with SNFs to create a modern care experience by enabling access to broader clinical resources and enhanced administrative support. Through our digital health solution, we aim to foster increased...
While SWI/SNF chromatin remodeling complex alterations occur in approximately 20% of cancer, the frequency and potential impact on clinical outcomes in meningiomas remains to be comprehensively elucidated. METHODS. A large series of 255 meningiomas from a single institution that was enriched for high ...
Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer[J]. Cancer Gene Ther, 2019, 26(11/12): 419-26. [16]Savas S, Skardasi G. The SWI/SNF complex subunit genes: their functions, variations, and links to risk and survival ...
domain with a particularly high PolyPhen score and average number of mutations; this region lacks 3D structural definition, implicating an alternative contribution to mSWI/SNF function (Fig.2f). Collectively, these results highlight convergent clinical outcomes stemming from mSWI/SNF gene disruption, ...
rates may also be increased with 2-level axial LIF. Controlled trials with clinical outcome measures are needed to better define the benefits and risks of this procedure compared with treatment alternatives. The evidence is insufficient to determine the effects of the technology on health outcomes. ...
and A.W.R initiated and conducted the AIM clinical trial, provided patient data, facilitated biospecimen collection and contributed to the interpretation of the research findings. S.-J.D. and M.A.D. developed the overall concept behind the study, supervised the experiments, analyzed the data ...
https://clinicaltrials.gov/ct2/show/NCT03480646. Yedier-Bayram, O. et al. EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities. Cell Death Dis. 13, 1–11 (2022). Article Google Scholar Li, W. et al. MAGeCK enables ...
2 Pages Open Document I am the person always want to learn new things. Keep myself motivated and passion. So I want to learn from the different working environment after I think it is time to change. I satisfied when my patient think I was trying my best to help them, from their smil...
Circulating tumor DNA alterations in advanced urothelial carcinoma and association with clinical outcomes: a pilot study Eur. Urol. Oncol. (2020)View more references Cited by (11) SMARCA2 protein: Structure, function and perspectives of drug design 2025, European Journal of Medicinal Chemistry Show ...